TapewireFind a company

person · Reporting owner

Song Hong Fang

Disclosed activity across 1 company

Tapewire entity
75778
SEC CIK
0002008157

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CG Oncology, Inc.CGON · Entity 3735DirectorSeptember 03, 2025September 04, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CG Oncology, Inc.

Report date September 03, 2025 · Filed September 04, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Chaming Jade Limited2,934,236 Reported balance After 2025-09-03 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2025-09-03 · Sale · Disposed 69,695 · Balance 2,934,236

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Common StockSEC Table I · non-derivativeIndirectBy Charming Jade Limited2,903,931 Last balance in matching sequence After 2025-09-03 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rows

Row 2 · 2025-09-03 · Sale · Disposed 30,105 · Balance 2,904,131

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Row 3 · 2025-09-03 · Sale · Disposed 100 · Balance 2,904,031

F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Row 4 · 2025-09-03 · Sale · Disposed 100 · Balance 2,903,931

F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Common StockSEC Table I · non-derivativeIndirectBy Unique Diamond Investments Limited586,982 Reported balance Holding disclosure · report date 2025-09-03 · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · Balance 586,982

F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

F5: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc.

Common StockSEC Table I · non-derivativeDirect613,928 Reported balance Holding disclosure · report date 2025-09-03 · row 6 Holding and transaction disclosures are not merged.
1 source row

Row 6 · Balance 613,928

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 03, 2025 Filed Sep 4, 2025 21:00 UTC CG Oncology, Inc. CGON · Entity 3735 SaleCommon Stock 100 $28.99 $2,899.00
Disclosure

SEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 4

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Charming Jade Limited

Disclosed balance after: 2,903,931

F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 21:00 UTC CG Oncology, Inc. CGON · Entity 3735 SaleCommon Stock 100 $28.96 $2,896.00
Disclosure

SEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 3

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Charming Jade Limited

Disclosed balance after: 2,904,031

F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 21:00 UTC CG Oncology, Inc. CGON · Entity 3735 SaleCommon Stock 30,105 $28.24 $850,165.20
Disclosure

SEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 2

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Charming Jade Limited

Disclosed balance after: 2,904,131

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 21:00 UTC CG Oncology, Inc. CGON · Entity 3735 SaleCommon Stock 69,695 $27.60 $1,923,582.00
Disclosure

SEC source: 0002008157-25-000004 · ownership.xml · nonDerivative · entry 1

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Chaming Jade Limited

Disclosed balance after: 2,934,236

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
June 05, 2025 Filed Jun 6, 2025 21:00 UTC CG Oncology, Inc. CGON · Entity 3735 GrantDirector Stock Option (right to buy) · Derivative 24,165 $0.00 Strike: $26.63 $0.00
Disclosure

SEC source: 0000950170-25-083239 · ownership.xml · derivative · entry 1

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,165

Underlying: Common Stock · 24,165 shares

Expires 2035-06-04

F1 · derivative.exercise_date: 1/12th of the total number of shares of common stock subject to the option vest monthly following June 5, 2025, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Read SEC document
December 16, 2024 Filed Dec 17, 2024 23:03 UTC CG Oncology, Inc. CGON · Entity 3735 SaleCommon Stock 700,000 $28.00 $19,600,000.00
Disclosure

SEC source: 0001415889-24-029664 · form4-12172024_111213.xml · nonDerivative · entry 1

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Charming Jade Limited

Disclosed balance after: 3,003,931

F1 · kind: The shares were offered and sold by Charming Jade Limited in connection with the Issuer's public offering pursuant to the Registration Statement on Form S-1 (File No. 333-283725) that closed on December 16, 2024.

F2 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.

F3 · ownership.nature: Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
October 04, 2024 Filed Oct 7, 2024 21:03 UTC CG Oncology, Inc. CGON · Entity 3735 GrantStock Option (Right to Buy) · Derivative 15,600 $0.00 Strike: $36.63 $0.00
Disclosure

SEC source: 0000950170-24-113304 · ownership.xml · derivative · entry 1

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,600

Underlying: Common Stock · 15,600 shares

Expires 2034-10-03

F1 · derivative.exercise_date: 1/12th of the total number of shares of common stock subject to the option vest monthly following October 4, 2024, the date of grant, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Read SEC document
August 29, 2024 Filed Aug 30, 2024 23:18 UTC CG Oncology, Inc. CGON · Entity 3735 SaleCommon Stock 226,245 $35.36 $8,000,023.20
Disclosure

SEC source: 0000950170-24-102496 · ownership.xml · nonDerivative · entry 2

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Charming Jade Limited

Disclosed balance after: 3,703,931

F2 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

F3 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P.

Read SEC document
August 29, 2024 Filed Aug 30, 2024 23:18 UTC CG Oncology, Inc. CGON · Entity 3735 SaleCommon Stock 424,210 $35.36 $15,000,065.60
Disclosure

SEC source: 0000950170-24-102496 · ownership.xml · nonDerivative · entry 1

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Unique Diamond Investments Limited

Disclosed balance after: 586,982

F1 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P.

F2 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 ConversionSeries E Preferred Stock · Derivative 37,474,236 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 8

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Charming Jade Limited

Disclosed balance after: 0

Underlying: Common Stock · 3,930,176 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

F4 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 ConversionSeries D Preferred Stock · Derivative 3,378,758 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 7

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Unique Diamond Investments Limited

Disclosed balance after: 0

Underlying: Common Stock · 354,353 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P.

F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 ConversionSeries C Preferred Stock · Derivative 6,262,967 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 6

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Unique Diamond Investments Limited

Disclosed balance after: 0

Underlying: Common Stock · 656,839 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P.

F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 ConversionSeries B Preferred Stock · Derivative 3,344,608 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · derivative · entry 5

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 350,771 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 PurchaseCommon Stock 263,157 $19.00 $4,999,983.00
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 4

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 613,928

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 ConversionCommon Stock 3,930,176 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 3

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Charming Jade Limited

Disclosed balance after: 3,930,176

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

F4 · ownership.nature: Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 ConversionCommon Stock 1,011,192 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 2

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Unique Diamond Investments Limited

Disclosed balance after: 1,011,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.nature: Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P.

F3 · ownership.nature: Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.

Read SEC document
January 29, 2024 Filed Jan 31, 2024 21:30 UTC CG Oncology, Inc. CGON · Entity 3735 ConversionCommon Stock 350,771 Not disclosed Not disclosed
Disclosure

SEC source: 0000950170-24-009429 · ownership.xml · nonDerivative · entry 1

Song Hong Fang · CIK 0002008157 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.